Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA)

NCT02567058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2015-10-02

No results posted yet for this study

Summary

Among Musculoskeletal disorders (MSD) the rupture of the Achilles tendon is the most common. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and that both in healthy subjects in pathology. The viscoelastic properties or dynamic mechanical properties are directly related to the tendon of the health status and its elongation capacity.

The laboratory UMR Inserm U930 - CNRS ERL 3106 in Tours has developed a non-invasive ultrasonic device, named Achillus, which, via an ultrasonic probe, allowing to access the viscoelastic properties of the tendon during the contraction of the sural triceps.

This is what we want to do in this first protocol: in vivo observation of the normal values and variations, looking for changes related to hyper solicitation and finally trying to highlight a tendon fragility parameter for patients who have experienced of a Achilles tendon rupture.

Conditions

  • Alterations of the Achilles Tendon

Interventions

DEVICE

Ultrasound exam

Ultrasound exam with : * 2 successions of 3 measures repeated for 2 visits (day 0 and day 21) for group I * 1 succession of 3 measures repeated for 4 visits (day 0, day 14, day 45, day 90)for group II * 1 succession of 3 measures for group III

BEHAVIORAL

IPAQ questionnaire

IPAQ questionnaire

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567058 on ClinicalTrials.gov